MedTrace Logo

Retrospective Study for Description of The Use Of Omalizumab In Patients With Difficult To Control Asthma

NCT01397760 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2011-07-20

No results posted yet for this study

Summary

The purpose of this study is do describe the experience in the use of omalizumabe, in a real life scenario, in uncontrolled severe asthmatic patients attended in specialist outpatient clinics, and its efficacy and safety. The efficacy of omalizumab in the population observed will be evaluated as reduction of uncontrolled asthma related events, i.e. exacerbations, emergency dept. visits, hospitalization and asthma-related treatment (decrease of asthma medication).

Conditions

Sponsors & Collaborators

  • Fiks, Iara Nely, M.D.

    lead INDIV

Principal Investigators

  • iara n fiks, md · pulmonary sao luiz hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-09-30
Completion
2011-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01397760 on ClinicalTrials.gov